A new technique in quantitative immunohematology: solid-phase kinetic enzyme-linked immunosorbent assay

Area of Science:

• Immunohematology
• Biochemistry
• Analytical Chemistry

Background:

• Accurate quantification of blood group antibodies is crucial for transfusion medicine and understanding immune responses.
• Existing methods may lack the sensitivity, specificity, or automation required for comprehensive immunohematology studies.

Purpose of the Study:

• To develop and validate a solid-phase kinetic enzyme-linked immunosorbent assay (ELISA) for quantifying antibodies against blood group antigens.
• To specifically test the assay's performance using chemically synthesized Lewis a antigen in the Lewis blood group system.
• To enable separate quantitation of IgG and IgM subclasses of anti-Lewis a antibodies.

Main Methods:

• Development of a solid-phase kinetic ELISA using a sandwich-type assay format.
• Utilized chemically synthesized Lewis a antigen as the target for antibody binding.
• Employed kinetic determinations for antibody quantitation, rather than endpoint measurements, and used semiautomated, commercially available reagents.

Main Results:

• The developed assay demonstrated quantitative, sensitive, and specific measurement of antibody binding.
• Successfully differentiated and quantified both IgG and IgM anti-Lewis a antibodies in patient sera.
• The assay proved robust and suitable for clinical applications.

Conclusions:

• The solid-phase kinetic ELISA is a reliable method for quantitative immunohematology.
• This assay provides a valuable tool for measuring specific antibody levels, particularly in the Lewis blood group system.
• The methodology is adaptable for use with other purified or synthetic blood group antigens as they become available.